Subscribe
Bioptigen has received 510(k) clearance from the FDA to begin marketing its hand-held spectral-domain optical coherence tomography (OCT) device (Envisu) for use in patients.
Anesthesia in children linked to learning disabilities?
Research grants help fight childhood blindness
Russia implements pediatric imaging program
IAPB general assembly set for September
Basil Williams, MD; Maura Di Nicola, MD
Deep Parikh, MD
Uday Devgan, MD, FACS, FRCS
Carl J. Danzig, MD, FASRS